Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
4(20%)
Results Posted
8%(1 trials)

Phase Distribution

Ph phase_1
2
10%
Ph phase_4
2
10%
Ph not_applicable
10
50%
Ph phase_2
4
20%
Ph phase_3
2
10%

Phase Distribution

2

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
2(10.0%)
Phase 2Efficacy & side effects
4(20.0%)
Phase 3Large-scale testing
2(10.0%)
Phase 4Post-market surveillance
2(10.0%)
N/ANon-phased studies
10(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

20

all time

Status Distribution
Active(7)
Completed(12)
Other(1)

Detailed Status

Completed12
Recruiting4
Not yet recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (10.0%)
Phase 24 (20.0%)
Phase 32 (10.0%)
Phase 42 (10.0%)
N/A10 (50.0%)

Trials by Status

completed1260%
unknown15%
not_yet_recruiting315%
recruiting420%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT06738043Not Applicable

Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery

Not Yet Recruiting
NCT07434310Phase 3

Use of Dexmedetomidine to Improve Pain Control and Recovery After Laparocopic-Assisted Bowel Surgery in Adults

Not Yet Recruiting
NCT06985290Phase 2

Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates

Not Yet Recruiting
NCT06970626Phase 2

Quality of Recovery in Laparoscopic Sleeve Gastrectomy Using Dexmedetomidine Infusion Versus Laparoscopic TAP Block in Combination With Paragastric Neural Block

Recruiting
NCT06970678Phase 1

Combining Dexmedetomidine Infusion and Paragastric Autonomic Neural Block to Enhance Postoperative Recovery in Patients Undergoing Laparoscopic Sleeve Gastrectomy

Recruiting
NCT05863416Phase 4

Dexmedetomidine in Non-intubated VATS

Recruiting
NCT06327399Phase 2

Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation.

Recruiting
NCT05283408Not Applicable

The Clinical Study of Dexmedetomidine and Esketamine Combined Infusion Undergoing Modified Radical Mastectomy

Completed
NCT03585452Not Applicable

Effects of Dexmedetomidine on Cognitive Outcome and Brain Injury Markers

Completed
NCT05345574Not Applicable

A Postoperative Sore Throat After Lumbar Spine Surgery in the Prone Position

Unknown
NCT03809923Not Applicable

Dexmedetomidine Combined With Lidocaine Infusion Affect PONV

Completed
NCT04706767Not Applicable

Effect of Co-administration Lidocaine and Dexmedetomidine on Quality of Recovery

Completed
NCT04935541Not Applicable

Dexmedetomidine vs. Remifentanil Undergoing Cataract Surgery in Geriatrics

Completed
NCT04148599Phase 3

Effect of IV Infusion of Lidocaine Compared to IV Infusion of Dexmedetomidine on Proinflammatory Cytokines

Completed
NCT03391609Phase 2

Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients

Completed
NCT01001429Phase 4

Dexmedetomidine Versus Propofol in Vitreoretinal Surgery

Completed
NCT01664520Phase 1

Dexmedetomidine and Subarachnoid Haemorrhage

Completed
NCT02185430Not Applicable

Effects of Dexmedetomidine on Respiratory Mechanics and Oxygenation During One Lung Ventilation With Chronic Obstructive Lung Disease

Completed
NCT01688648Not Applicable

Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft

Completed
NCT01572454Not Applicable

Comparison of Dexmedetomidine and Remifentanil Infusion During CABG

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20